We observed two distinct responses to Hsp90 inhibitors in small cell lung cancer cells, the first being the premature senescence described above and the second being cell death, which is seen at much higher concentrations of Hsp90 inhibitors. This evidence concerns the gene HSP90AA1 and small cell lung carcinoma.